-
Jennifer Winter, Chief Executive Officer
Appointment:
Jennifer was appointed as Chief Executive Officer of the Group in 2018.
Committee membership:
N/A; attends some Committee meetings by invitation.
Responsibilities, relevant skills and experience:
As CEO, Jennifer has responsibility for developing and executing the Group’s strategy as approved by the Board and drives the performance and results of the Group. She manages Group operations in conjunction with the Leadership Team. With her background in the healthcare sector, including senior commercial roles at AstraZeneca and GlaxoSmithKline, Jennifer brings significant experience of product development, change management, marketing and communications.
She was a Non-Executive Director of Allied Irish Bank from 2004 to 2010, and Chief Executive Officer of Barretstown from 2003 to 2007, transforming it into a successful, leading children’s charity.
Jennifer has a BSc in Physiology and Pharmacology from the University of Southampton.
Key external appointments:
Jennifer is a Non-Executive Director of EKF Diagnostics Holdings plc and a Trustee Director and Chair of the Trustees of Royal Brompton and Harefield Hospitals Charity.
-
Chris Brewster, Chief Financial Officer and Company Secretary
Appointment:
Chris was appointed Chief Financial Officer in 2012.
Committee membership:
N/A; attends the Audit and Risk Committee by invitation.
Responsibilities, relevant skills and experience:
Since joining Animalcare in 2012, Chris has gained significant animal health sector experience and works alongside Jennifer in developing and executing the Group strategy. His responsibilities cover finance, risk management, Group IT and legal. Chris is the Board member responsible for Sustainability.
Chris is a Chartered Accountant, having qualified with KPMG in 2003. Before joining Animalcare he worked as Group Accounting Manager at Findus.
Key external appointments:
None
-
Dr Doug Hutchens, Independent Non-Executive Director
Appointment:
Doug was appointed to the Board on 10 February 2022.
Committee membership:
Chair of Remuneration & Nomination Committee and member of the Audit & Risk Committee.
Responsibilities, relevant skills and experience:
Doug has held several senior positions in research and development (R&D) and regulatory affairs at leading global animal health companies. As part of the executive team at Bayer Animal Health, he was an Executive Vice President and Chief Veterinary Officer where he led both drug discovery and product development on a global basis.
Before joining the animal health pharmaceutical industry, Doug was an Assistant Professor at the University of Illinois College of Veterinary Medicine where he conducted studies for most of the major animal health companies and participated in the development of multiple new products for companion and production animals. Early in his career, he was a practising veterinarian. He holds a Doctor of Veterinary Medicine degree and a PhD in pathobiology with an emphasis in immuno-parasitology from the University of Illinois.
Key external appointments:
Doug is Chief Scientific Officer at Animol Discovery, Inc in the US and on the advisory board of ClinGlobal Limited, which is based in Mauritius.
